Pregenen
Pregenen designs and engineers molecules critical to a new generation of cell-based therapies for unmet medical needs.
Launch date
Employees
Market cap
-
Enterprise valuation
$140m (Public information from Jul 2014)
Seattle Washington (HQ)
Authorizing premium user...